Form 8-K - Current report:
SEC Accession No. 0000950170-24-114466
Filing Date
2024-10-15
Accepted
2024-10-15 08:00:09
Documents
11
Period of Report
2024-10-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K bold-20241011.htm   iXBRL 8-K 40925
  Complete submission text file 0000950170-24-114466.txt   159260

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bold-20241011.xsd EX-101.SCH 25994
13 EXTRACTED XBRL INSTANCE DOCUMENT bold-20241011_htm.xml XML 4934
Mailing Address 9880 CAMPUS POINT DRIVE SUITE 120 SAN DIEGO CA 92121
Business Address 9880 CAMPUS POINT DRIVE SUITE 120 SAN DIEGO CA 92121 (858) 766-9912
Boundless Bio, Inc. (Filer) CIK: 0001782303 (see all company filings)

EIN.: 830751369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41989 | Film No.: 241369334
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)